Skip to main content
. 2022 Feb 4;76:103846. doi: 10.1016/j.ebiom.2022.103846

Figure 1.

Figure 1

SOX9 upregulation in Crohn's disease and TNBS-induced colitis mice. a, SOX9 expression in CD and HC by RT-qPCR (CD, n = 35; HC, n = 35); b-c, SOX9 expression in CD and HC by immunoblotting (CD, n = 10; HC, n = 10); d-f, SOX9 expression in TNBS-induced colitis mice and normal controls by RT-qPCR and immunoblotting (TNBS, n = 8; Controls, n = 8); g-h, IHC staining for SOX9 expression (CD, n = 10; HC, n = 10; TNBS, n = 8; Controls, n = 8). Scale bars, 100 μm in (g) and 50 μm in (h). All data are reported as means ± SEM in (a), (b), (d), (e) and Student's t-test were used for comparison.